Development of a Prognostic Model Based on the Identification of EMT-Related lncRNAs in Triple-Negative Breast Cancer

Figure 3

Clinical predictive value of the model. (a) Relationship between the model and tumor immune infiltration. (b) Relationship between the model and sensitivity of common chemotherapy drugs. (c) Mutation spectrum of high-/low-risk groups (left: high-risk group; right: low-risk group).

(a)

(b)

(c)